PCM
LFMD icon

Prelude Capital Management’s LifeMD LFMD Stock Holding History

Prelude Capital Management’s Portfolio LFMD Stock Details LFMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-51,425
Closed -$175K – 1430
2025
Q4 		$175K Sell
51,425
-39,388
-43% -$191K 0.01% 1092
2025
Q3 		$617K Buy
+90,813
New +$750K 0.05% 441
2024
Q3 		– Sell
-30,858
Closed -$212K – 1428
2024
Q2 		$212K Buy
+30,858
New +$282K 0.01% 975
2022
Q1 		– Sell
-22,607
Closed -$87K – 2046
2021
Q4 		$87K Buy
+22,607
New +$107K ﹤0.01% 1743

Other funds holding LFMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return
BRF
B. Riley Financial Los Angeles, California $434M AUM 751.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Prelude Capital Management's LFMD Position: Q1 2026 in Review

Prelude Capital Management sold out of LifeMD (LFMD) in Q1 2026, closing a stake of 51,425 shares — an estimated $175K sold.

Prelude Capital Management first reported a position in LFMD in Q4 2021 and held it in 4 quarters. The position peaked at $617K in Q3 2025. 102 funds tracked by Wall St. Rank hold LFMD as of Q1 2026.

  • Prelude Capital Management reported no remaining LifeMD position as of Q1 2026 after selling out during the quarter.
  • Prelude Capital Management sold 51,425 LifeMD shares in Q1 2026, an estimated $175K.
  • Prelude Capital Management first reported a position in LifeMD in Q4 2021 and held it in 4 quarters.
  • Prelude Capital Management's LifeMD position peaked at $617K in Q3 2025.
  • 102 funds tracked by Wall St. Rank held LifeMD as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.